Rus
Eng
Professor Yury Gogotsi, Drexel University was awarded with prestigious 2016 Nano Energy Award at the 2nd International Conference on Nanoenergy and Nanosystems that was held in Beijing International Convention Center, July 13-15, 2016, Beijing, China.
This award recognizes an outstanding researcher in the field of nano energy whose work reflects the interdisciplinarity of this field has contributed in an innovative and/or impactful way to solving the major energy problems facing society.
The Awards Committee received a number of high caliber nominations this year, but Professor Gogotsi’s nomination was ranked highest in terms of meeting the criteria for the award.
Prof. Yury Gogotsi is Distinguished University Professor and Trustee Cha ir of Materials Science and Engineering at Drexel University. He is the founding Director of the A.J. Drexel Nanomaterials Institute and Associate Editor of ACS Nano.
He works on nanostructured carbons and two - dimensional carbides for energy related and biomedical applications. His work on synthesis of new carbon and carbide nanomaterials with tunable structure and porosity had a major impact on the field of capacitive energy storage.
Prof. Yury Gogotsi has co-authored 2 books, more than 400 journal papers and obtained mor e than 50 patents. He has received numerous national and international awards for his research, with the latest one being the 2015 Nanotechnology International Prize from RUSNANO.
He was recognized as a Highly Cited Researcher by Thomson - Reuters in 2014 an d 2015, and elected a Fellow of AAAS, MRS, ECS, RSC, ACerS and the World Academy of Ceramics.
Related News
| Congratulations to Prof. Gogotsi on winning the 2016 Nano Energy Award! |
The award will be presented to prof. Yury Gogotsi at the Nanoenergy and Nanosystems 2016 conference, which will be held in Beijing between 13-15 July 2016.
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
